Ori Folger
Ori Folger
Unknown affiliation
Verified email at post.tau.ac.il
Title
Cited by
Cited by
Year
Predicting selective drug targets in cancer through metabolic networks
O Folger, L Jerby, C Frezza, E Gottlieb, E Ruppin, T Shlomi
Molecular systems biology 7 (1), 501, 2011
4792011
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
C Frezza, L Zheng, O Folger, KN Rajagopalan, ED MacKenzie, L Jerby, ...
Nature 477 (7363), 225-228, 2011
4332011
The spliceosome as an indicted conspirator in myeloid malignancies
O Abdel-Wahab, R Levine
Cancer cell 20 (4), 420-422, 2011
422011
Flux balance analysis accounting for metabolite dilution
T Benyamini, O Folger, E Ruppin, T Shlomi
Genome biology 11 (4), 1-9, 2010
402010
Adaptive recommendation system
N Nice, D Kremer, D Sitton, M Feldman, S Shlevich, O Folger
US Patent 9,208,155, 2015
262015
Recommender system
N Nice, S Keren, O Folger, U Paquet, S Shlevich, N Koenigstein, E Yogev
US Patent App. 13/400,581, 2013
52013
Method and system for predicting selective cancer drug targets
E Ruppin, T Shlomi, O Folger, E Gottlieb, C Frezza
US Patent App. 15/086,672, 2016
22016
Method and system for predicting selective cancer drug targets
E Ruppin, T Shlomi, O Folger, E Gottlieb, C Frezza
US Patent App. 13/410,950, 2012
12012
Supplementary Online Material Predicting Selective Drug Targets in Cancer through Metabolic Networks
O Folger, L Jerby, C Frezza, E Gottlieb, E Ruppin, T Shlomi
The system can't perform the operation now. Try again later.
Articles 1–9